Carrick Therapeutics Limited   Report issue

For profit Phase 2
Founded: Dublin Ireland (2015)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2017
NCT03363893
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Carrick Therapeutics Limited

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4